Revolution or Risk? Weighing the Impact of Obesity Drugs on Societal Health

February 03
6-8pm
Kimmel Center for University Life, 60 Washington Sq South, 10th Flr, New York, NY

Discover how GLP-1 drugs—game-changing medications like Ozempic and Mounjaro—are reshaping weight management and health care for millions. While their benefits are undeniable, these drugs also raise pressing questions about long-term safety, skyrocketing costs, and unequal access. In this thought-provoking event, faculty experts will delve into the medical, ethical, and societal implications of GLP-1 drugs. From the role of telehealth and social media in accessibility to the broader challenges of equitable care, this discussion will offer valuable insights for healthcare professionals, policymakers, and anyone curious about the future of obesity treatment. Don’t miss this opportunity to explore one of the most significant advancements in modern medicine.

Speakers:

Virginia W. Chang, MD, PhD, Associate Professor of Global Public Health and Associate Professor of Population Health

Angela Godwin Beoku-Betts, MSN, DNP, FNP-BC, Clinical Assistant Professor, NYU Rory Meyers College of Nursing

Moderated by:

Rachel Harrison, Associate Director, Research Communications

 


6:00 PM | Reception 

7:00 PM | Faculty Panel Discussion

NYU alumni events are generally intended for and open to all  graduates of NYU and when space permits, their guests; all NYU alumni  are welcome to attend, regardless of identity. Many of our events are  open to the wider NYU community of parents, students, and friends. If  you have questions about a particular event, please contact the event  planner.

Photo and/or video may be taken at this event. By registering and attending, you consent to being recorded. Images may be used in future NYU publications and materials. If you would prefer not to be photographed, please inform the photographer.